TY - JOUR
T1 - Pallidal deep brain stimulation modulates excessive cortical high β phase amplitude coupling in Parkinson disease
AU - Malekmohammadi, Mahsa
AU - AuYong, Nicholas
AU - Ricks-Oddie, Joni
AU - Bordelon, Yvette
AU - Pouratian, Nader
N1 - Funding Information:
This work was supported by the National Institute of Biomedical Imaging and Bioengineering [ K23 EB014326 ], National Institute of Neurological Disorders and Stroke [ R01NS097782 ] and philanthropic support from Casa Colina Centers for Rehabilitation . NA was supported by National Institute of Neurological Disorders and Stroke [ R25-NS079198 ]. MM also was supported by postdoctoral fellowship from American Parkinson Disease Association (APDA , NY).
Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Objective: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and globus pallidus internus (GPi) are equally efficacious in the management of Parkinson disease (PD). Studies of STN-DBS have revealed a therapeutic reduction in excessive cortical β-γ phase-amplitude coupling (PAC). It is unclear whether this is specific to STN-DBS and potentially mediated by modulation of the hyperdirect pathway or if it is a generalizable mechanism seen with DBS of other targets. Moreover, it remains unclear how cortical signals are differentially modulated by movement versus therapy. To clarify, the effects of GPi-DBS and movement on cortical β power and β-γ PAC were examined. Methods: Right sensorimotor electrocorticographic signals were recorded in 10 PD patients undergoing GPi-DBS implantation surgery. We evaluated cortical β power and β-γ PAC during blocks of rest and contralateral hand movement (finger tapping) with GPi-DBS off and on. Results: Movement suppressed cortical low β power (P = 0.008) and high β-γ PAC (P = 0.028). Linear mixed effect modeling (LMEM) showed that power in low and high β bands are differentially modulated by movement (P = 0.022). GPi-DBS also results in a significant suppression of high β-γ PAC but without power modulation in either β sub-band (P = 0.008). Cortical high β-γ PAC is significantly correlated with severity of bradykinesia (Rho = 0.59, P = 0.045) and changes proportionally with therapeutic improvement (Rho = 0.61, P = 0.04). Conclusions: Similar to STN-DBS, GPi-DBS reduces motor cortical β-γ PAC, like that also reported with dopaminergic mediations, suggesting it is a generalizable symptom biomarker in PD, independent of therapeutic target or proximity to the hyperdirect pathway.
AB - Objective: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and globus pallidus internus (GPi) are equally efficacious in the management of Parkinson disease (PD). Studies of STN-DBS have revealed a therapeutic reduction in excessive cortical β-γ phase-amplitude coupling (PAC). It is unclear whether this is specific to STN-DBS and potentially mediated by modulation of the hyperdirect pathway or if it is a generalizable mechanism seen with DBS of other targets. Moreover, it remains unclear how cortical signals are differentially modulated by movement versus therapy. To clarify, the effects of GPi-DBS and movement on cortical β power and β-γ PAC were examined. Methods: Right sensorimotor electrocorticographic signals were recorded in 10 PD patients undergoing GPi-DBS implantation surgery. We evaluated cortical β power and β-γ PAC during blocks of rest and contralateral hand movement (finger tapping) with GPi-DBS off and on. Results: Movement suppressed cortical low β power (P = 0.008) and high β-γ PAC (P = 0.028). Linear mixed effect modeling (LMEM) showed that power in low and high β bands are differentially modulated by movement (P = 0.022). GPi-DBS also results in a significant suppression of high β-γ PAC but without power modulation in either β sub-band (P = 0.008). Cortical high β-γ PAC is significantly correlated with severity of bradykinesia (Rho = 0.59, P = 0.045) and changes proportionally with therapeutic improvement (Rho = 0.61, P = 0.04). Conclusions: Similar to STN-DBS, GPi-DBS reduces motor cortical β-γ PAC, like that also reported with dopaminergic mediations, suggesting it is a generalizable symptom biomarker in PD, independent of therapeutic target or proximity to the hyperdirect pathway.
KW - Deep brain stimulation
KW - Globus pallidus internus
KW - Motor cortex
KW - Parkinson disease
KW - Phase amplitude coupling
UR - http://www.scopus.com/inward/record.url?scp=85044940310&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044940310&partnerID=8YFLogxK
U2 - 10.1016/j.brs.2018.01.028
DO - 10.1016/j.brs.2018.01.028
M3 - Article
C2 - 29422442
AN - SCOPUS:85044940310
SN - 1935-861X
VL - 11
SP - 607
EP - 617
JO - Brain Stimulation
JF - Brain Stimulation
IS - 3
ER -